Hersha Hospitality Trust Announces New $50 Million Share Repurchase Program
PHILADELPHIA, Dec. 20, 2018 (GLOBE NEWSWIRE) — Hersha Hospitality Trust (NYSE: HT) (“Hersha” or the “Company”), owner of high-quality upscale, […]
BlackRock® Canada Announces Estimated Annual Reinvested Capital Gains Distributions for the iShares® ETFs
TORONTO, Dec. 20, 2018 (GLOBE NEWSWIRE) — BlackRock Asset Management Canada Limited (“BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock, […]
Plantronics Cloud Solutions Finish Strong in 2018 for Customers and Partners
Company Releases Updated Version of Plantronics Manager Pro and Announces Momentum of Polycom Device Management Services with Service Providers SANTA […]
Saratoga Investment Corp. to Report Fiscal Third Quarter 2019 Financial Results and Hold Conference Call
NEW YORK, Dec. 20, 2018 (GLOBE NEWSWIRE) — Saratoga Investment Corp. (NYSE:SAR), a business development company, will report its financial […]
Replimune to Present at the 37th Annual J.P.Morgan Healthcare Conference
WOBURN, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) — Replimune Group Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immunotherapies derived […]
Cue Biopharma and LG Chem Life Sciences Announce WT1 as the Next Immuno-STAT™ Target in Oncology
WT1 is a Well-Characterized Oncofetal Antigen, Expressed in Solid Tumors and Hematologic Malignancies CAMBRIDGE, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) — […]
FuelCell Energy Subsidiary Executes Power Purchase Agreement For Long Island 7.4 MW Fuel Cell Project
20-Year Power Purchase Agreement executed for 7.4 MW Project in Yaphank, NY Advances LIPA and PSEG Long Island efforts to […]
VBI Vaccines Announces Phase 2 Clinical Study Design of its Prophylactic CMV Vaccine Candidate
CAMBRIDGE, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) — VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation […]
Synthorx Appoints Andrew Powell, J.D., to its Board of Directors
Pratik Shah., Ph.D., Appointed Chairman of the Board SAN DIEGO, Dec. 20, 2018 (GLOBE NEWSWIRE) — Synthorx, Inc. (NASDAQ: THOR), […]
Retrophin Completes Enrollment of Pivotal Phase 3 FORT Study of Fosmetpantotenate in PKAN
Top-line data anticipated in the third quarter of 2019 SAN DIEGO, Dec. 20, 2018 (GLOBE NEWSWIRE) — Retrophin, Inc. (NASDAQ: […]
